Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT01360125
First received: May 21, 2011
Last updated: April 14, 2016
Last verified: April 2016